Midwifery Medications Quiz for Students

Depo Provera contains medroxyprogesterone acetate, a progestational hormone administered every three months intramuscularly. It suppresses ovulation by inhibiting pituitary gonadotropin secretion. Without ovulation, fertilization cannot occur. It also thickens cervical mucus, reducing sperm penetration. Clinical data shows contraceptive efficacy exceeding ninety percent with proper use. Its hormonal mechanism clearly defines its primary indication as pregnancy prevention.

Dulcolax contains bisacodyl, a stimulant laxative that directly activates intestinal nerve plexuses. This stimulation increases peristalsis and enhances water accumulation in the colon, promoting bowel evacuation. It is commonly used for short-term constipation relief or bowel preparation. Overuse may cause fluid imbalance. Its mechanism and therapeutic outcome clearly categorize it as a laxative medication.

Magnesium Sulfate acts as a central nervous system depressant and reduces neuromuscular transmission by competing with calcium at motor end plates. In obstetrics, it prevents seizures associated with preeclampsia and eclampsia. Therapeutic monitoring includes reflexes and respiratory status. Elevated serum magnesium levels can cause respiratory depression. Its seizure-prevention function defines its obstetric therapeutic importance.

Pitocin is synthetic oxytocin that binds to uterine oxytocin receptors, increasing intracellular calcium levels in myometrial cells. Elevated calcium stimulates rhythmic uterine contractions necessary for labor progression. It is also used postpartum to reduce bleeding by enhancing uterine tone. Excessive dosing may cause fetal distress. Its receptor-based uterotonic effect defines its obstetric role.

Rhogam is Rh immune globulin administered to Rh-negative mothers to prevent formation of antibodies against Rh-positive fetal red blood cells. It suppresses maternal immune sensitization by neutralizing fetal cells before antibody production occurs. Standard dosing includes 300 micrograms at twenty-eight weeks and within seventy-two hours postpartum. Its immunologic mechanism prevents hemolytic disease in future pregnancies.

Cytotec contains misoprostol, a prostaglandin E1 analog that reduces gastric acid secretion and increases protective mucus production. It is prescribed to prevent NSAID-induced gastric ulcers. In obstetrics, it stimulates uterine contractions by acting on smooth muscle receptors. Because it can induce uterine activity, it carries miscarriage risk. Its dual gastrointestinal and uterotonic effects explain its classification and primary clinical use.

Dilaudid, or hydromorphone, is a potent opioid analgesic that binds to mu-opioid receptors in the central nervous system. This interaction alters pain perception and emotional response to discomfort. It is significantly stronger than morphine on a milligram basis. Because of respiratory depression risk, monitoring is required. Its pharmacologic mechanism confirms its indication for managing severe pain conditions.

Ibuprofen is a nonsteroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes responsible for prostaglandin synthesis. Reduced prostaglandins decrease inflammation, pain, and fever. Because prostaglandins also protect gastric lining, inhibition may increase gastrointestinal irritation risk. Doses typically range from 200 to 400 milligrams every four to six hours. Its biochemical pathway confirms prostaglandin inhibition as its principal action.

Phenergan contains promethazine, an H1 receptor antagonist that blocks histamine activity in central and peripheral tissues. It also exhibits anticholinergic and sedative properties. These actions reduce allergic symptoms such as itching and swelling. Because it depresses the central nervous system, drowsiness is common. Its antihistamine and antiemetic effects confirm its primary therapeutic purpose.

Morphine injection is an opioid analgesic that activates central opioid receptors to block pain transmission pathways. It decreases perception of pain and induces sedation. Because it suppresses respiratory centers, oxygen saturation must be monitored. It is commonly administered epidurally or intravenously for severe pain. Its receptor-mediated mechanism confirms classification as an opioid analgesic.

Nubain, or nalbuphine, is an opioid agonist-antagonist that provides analgesia while partially limiting respiratory depression compared to full agonists. It binds to kappa receptors and antagonizes mu receptors. It is used for moderate to severe pain and preoperative sedation. Dosing is weight-based. Its pharmacologic receptor interaction explains its clinical application in pain control.

Methergine contains methylergonovine, an ergot alkaloid that increases uterine muscle tone and contraction frequency. It is administered postpartum to reduce uterine atony and hemorrhage. By sustaining uterine contraction, it compresses blood vessels and limits bleeding. Hypertension is a known side effect due to vasoconstriction. Its pharmacodynamic profile explains its targeted use in postpartum hemorrhage management.

Toradol, or ketorolac, is a potent NSAID indicated for short-term management of moderate to severe pain. It inhibits prostaglandin synthesis similarly to other NSAIDs but carries increased gastrointestinal and renal risk. Therapy duration should not exceed five days due to bleeding potential. Its analgesic potency without opioid receptor activity supports its classification as short-term pain management medication.